| Chimeric aptamers in cancer cell-targeted drug delivery JR Kanwar, K Roy, RK Kanwar Critical reviews in biochemistry and molecular biology 46 (6), 459-477, 2011 | 171 | 2011 |
| Multifunctional Iron Bound Lactoferrin and Nanomedicinal Approaches to Enhance Its Bioactive Functions JR Kanwar, K Roy, Y Patel, SF Zhou, MR Singh, D Singh, M Nasir, ... Molecules 20 (6), 9703-9731, 2015 | 165 | 2015 |
| LNA aptamer based multi-modal, Fe 3 O 4-saturated lactoferrin (Fe 3 O 4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging K Roy, RK Kanwar, JR Kanwar Biomaterials 71, 84-99, 2015 | 98 | 2015 |
| Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zinc JR Kanwar, G Mahidhara, K Roy, S Sasidharan, S Krishnakumar, ... Nanomedicine 10 (1), 35-55, 2015 | 83 | 2015 |
| Nucleic Acid-Based Aptamers: Applications, Development and Clinical Trials J R Kanwar, K Roy, N G Maremanda, K Subramanian, R N Veedu, ... Current medicinal chemistry 22 (21), 2539-2557, 2015 | 59 | 2015 |
| Molecular targets in arthritis and recent trends in nanotherapy R Kislay, K Rupinder, Kaur, K Jagat, Rakesh International Journal of Nanomedicine, 2015 | 56 | 2015 |
| Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition SL Edwards, V Poongavanam, JR Kanwar, K Roy, KM Hillman, N Prasad, ... Chemical Communications 51 (46), 9499-9502, 2015 | 56 | 2015 |
| Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors SN Aasen, H Parajuli, T Hoang, Z Feng, K Stokke, J Wang, K Roy, ... International journal of molecular sciences 20 (17), 4235, 2019 | 54 | 2019 |
| EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs J Macdonald, J Henri, K Roy, E Hays, M Bauer, RN Veedu, N Pouliot, ... Cancers 10 (1), 19, 2018 | 53 | 2018 |
| Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases JR Kanwar, RR Mohan, RK Kanwar, K Roy, R Bawa Nanomedicine 5 (9), 1435-1445, 2010 | 52 | 2010 |
| Oral administration of iron-saturated bovine lactoferrin–loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism G Mahidhara, RK Kanwar, K Roy, JR Kanwar International journal of nanomedicine 10, 4081, 2015 | 48 | 2015 |
| Recent advances in nanomedicine and survivin targeting in brain cancers J Mazur, K Roy, JR Kanwar Nanomedicine 13 (1), 105-137, 2018 | 45 | 2018 |
| Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents R Chaudhary, K Roy, RK Kanwar, K Walder, JR Kanwar Journal of nanobiotechnology 14 (1), 6, 2016 | 41 | 2016 |
| Comparative activities of milk components in reversing chronic colitis JR Kanwar, RK Kanwar, S Stathopoulos, NW Haggarty, AKH MacGibbon, ... Journal of dairy science 99 (4), 2488-2501, 2016 | 35 | 2016 |
| Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells NG Maremanda, K Roy, RK Kanwar, V Shyamsundar, V Ramshankar, ... Biomicrofluidics 9 (5), 054110, 2015 | 31 | 2015 |
| Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells KRYSPRKKRRXWJR Kanwar · International Journal of Nanomedicine, 2015 | 30* | 2015 |
| Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model K Roy, RK Kanwar, S Krishnakumar, CHA Cheung, JR Kanwar International journal of nanomedicine 10, 1019, 2015 | 29 | 2015 |
| Characterization and Molecular Mechanism of Peptide-Conjugated Gold Nanoparticle Inhibiting p53-HDM2 Interaction in Retinoblastoma S Kalmodia, S Parameswaran, K Ganapathy, W Yang, CJ Barrow, ... Molecular Therapy-Nucleic Acids 9, 349-364, 2017 | 24 | 2017 |
| Locked nucleic acid modified bi-specific aptamer-targeted nanoparticles carrying survivin antagonist towards effective colon cancer therapy K Roy, RK Kanwar, CHA Cheung, CL Fleming, RN Veedu, ... RSC Advances 5 (37), 29008-29016, 2015 | 20 | 2015 |
| Survivin Modulators: An Updated Patent Review (2011-2015) K Roy, N Singh, R K Kanwar, J R Kanwar Recent patents on anti-cancer drug discovery 11 (2), 152-169, 2016 | 17 | 2016 |
Dr Rupinder K KanwarAll India Institute of Medical Sciences (AIIMS), Bhopal, M.P. IndiaVerified email at aiimsbhopal.edu.in